LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 3.94 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $461,000 | -16.3% | 82,915 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $551,000 | -68.9% | 82,915 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,770,000 | +76.3% | 165,830 | +98.2% | 0.00% | 0.0% |
| Q2 2018 | $1,004,000 | +51.7% | 83,674 | +8.4% | 0.00% | 0.0% |
| Q1 2018 | $662,000 | -13.2% | 77,189 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $763,000 | -19.6% | 77,189 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $949,000 | -25.3% | 77,189 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $1,270,000 | +24.5% | 77,189 | +8.5% | 0.00% | +100.0% |
| Q1 2017 | $1,020,000 | -31.0% | 71,112 | -33.5% | 0.00% | -50.0% |
| Q4 2016 | $1,478,000 | +2.9% | 106,890 | +34.4% | 0.00% | 0.0% |
| Q3 2016 | $1,437,000 | +47.7% | 79,512 | +17.3% | 0.00% | 0.0% |
| Q2 2016 | $973,000 | +35.7% | 67,782 | +12.9% | 0.00% | +100.0% |
| Q1 2016 | $717,000 | -10.3% | 60,041 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $799,000 | +23.9% | 60,041 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $645,000 | +33.5% | 60,041 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $483,000 | – | 60,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |